Browsed by
Category: Press Releases

Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into a definitive agreement with Chimerix, Inc. (NASDAQ: CMRX), to acquire Chimerix’s exclusive worldwide rights to TEMBEXA® (brincidofovir), the first antiviral approved by the U.S. Food and Drug Administration (FDA) for all age groups for the treatment of smallpox. TEMBEXA was approved in June 2021 and is indicated for the treatment of human smallpox disease in adult and pediatric patients, including neonates. ...  Read more

QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.

QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.

HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has signed agreements to acquire a 96% majority ownership stake in BLIRT SA (Polish Stock Exchange: BLR), a manufacturer of recombinant enzymes for the life science industry based in Gdansk, Poland.  ...  Read more

Stonebridge Selects Transwestern to Lease EvolutionLabs at Washingtonian

Stonebridge Selects Transwestern to Lease EvolutionLabs at Washingtonian

Stonebridge announced today that it has selected Transwestern to lease its first purpose-built lab development – EvolutionLabs at Washingtonian – a two-building, 250,000-square foot-project at 9713 Washington Boulevard. The first 150,000-square-foot, six-story building will break ground this fall and be ready for tenant construction in winter 2024. The second 100,000-square-foot building is expected to start construction in 2024. The Washingtonian project is a joint venture between Stonebridge and Principal Real Estate Investors. ...  Read more

Apply for MIPS funding to accelerate your technology-based product development

Apply for MIPS funding to accelerate your technology-based product development

The Maryland Industrial Partnerships (MIPS) program provides funding for university research projects that help companies develop new technology products. With MIPS matching funds, companies can leverage the facilities, resources, and expertise within Maryland’s public universities to create new products and opportunities. ...  Read more